Poor penetration of drug delivery nanocarriers within dense extracellular matrices constitutes one of the main liabilities of current nanomedicines. The conjugation of proteolytic enzymes on the nanoparticle surface constitutes an attractive alternative. However, the scarce resistance of these enzymes against the action of proteases or other aggressive agents present in the blood stream strongly limits their application. Herein, a novel nanodevice able to transport proteolytic enzymes coated with an engineered pH-responsive polymeric is presented. This degradable coat protects the housed enzymes against proteolytic attack at the same time that it triggers their release under mild acidic conditions, usually present in many tumoral tissues. These enzyme 2 nanocapsules have been attached on the surface of mesoporous silica nanoparticles, as nanocarrier model, showing a significatively higher penetration of the nanoparticles within 3D collagen matrices which housed Human Osteosarcoma cells (HOS). This strategy can improve the therapeutic efficacy of the current nanomedicines allowing a more homogeneous and deeper distribution of the therapeutic nanosystems in cancerous tissues.
INTRODUCTION
Nanoparticles have become a powerful weapon in the fight against cancer due to their passive accumulation within solid tumors (EPR effect). 1 This effect is caused by the distinctive tumoral blood vessels which present large pores and fenestrations of few hundred nanometers. 2 Thus, when the nanoparticles reach the tumoral zone, they are able to escape from these highly permeable blood vessels producing the accumulation in the diseased tissue. 3 Despite the huge importance of reaching the tumoral area, this is only the first step. The extravasated nanocarrier should be able to penetrate deeper into the solid tumor if a high therapeutic efficacy is pretended.
Unfortunately, there are several physiological and physical barriers that should be overcome in order to achieve a homogeneous nanocarrier distribution in the entire malignant tissue. 4 Tumoral tissues exhibit elevated interstitial fluid pressure (IFP) which hampers the convective transport making diffusion the de facto sole transport mechanism for nanocarriers. Moreover, solid tumors usually present extracellular matrices (ECM) denser than healthy tissues, with higher collagen 3 content which hinders even more the nanocarrier diffusion. 5 The lack of an efficient nanoparticle distribution throughout all the diseased tissue reduces considerably the therapeutic efficiency of the nanomedicines and is one of their main liabilities. 6 Different strategies have been postulated in order to overcome this limitation. Thus, the nanocarrier surface decoration with cell penetrating peptides (CPP) in combination with magnetic field guidance 7 and even the use of self-propelled devices have been described to achieve a higher penetration in 3D tissues. 8 A simpler approach consists in the local administration of proteolytic enzymes prior to the nanocarrier treatment, which has demonstrated a significant nanoparticle penetration enhancement within the tumoral tissue. 9 Different proteolytic enzymes such as collagenase or bromelain have been directly anchored on the nanoparticle surface improving their diffusion in comparison with non-functionalized particles. 10, 11 However, enzymes are labile entities which can suffer a rapid degradation in living tissues by the action of proteases or other aggressive agents present in the blood stream. Even the attachment method can compromise the enzymatic activity as a consequence of conformational changes or active site blockage. 12 Lu et al. 13, 14 have reported an interesting strategy which consists in the enzyme encapsulation into polymeric nanocapsules in order to improve their resistance and to preserve their activity during longer times. Our research group has described the attachment of enzyme nanocapsules onto the nanoparticle surface for the development of devices able to generate in situ cytotoxic compounds 15 and also for the propulsion of nano-and micromotors. 16 Herein, we describe the design and attachment of hybrid collagenase-polymeric nanocapsules on the surface of mesoporous silica nanoparticles in order to improve their penetration within 3D collagen matrices with tumoral cells embedded within the network, which mimic tumoral tissues. These polymeric nanocapsules protect the enzyme against proteolytic degradation and hydrolysis 4 during longer times improving enzyme performance while allowing higher matrix degradation and therefore, deeper penetration within the tissue (Scheme 1). Scheme 1. Synthesis and mechanism of pH-responsive polymeric nanocapsules for enhanced extracellular matrix degradation and tumoral tissue penetration.
RESULTS AND DISCUSSION
Synthesis and performance evaluation of the collagenase nanocapsules.
Collagen is the most abundant component of the extracellular matrix. Thus, collagenase is one of the most suitable enzymes for ECM degradation. As mentioned above, a polymeric coating was built around the enzyme in order to preserve the activity against aggressive agents. The enzyme substrate is a big molecule and therefore, the enzyme should be released from the capsule in order to be active for efficient collagen degradation. For this reason, a pH-responsive polymeric nanocapsule has been designed. This polymer coating undergoes slow degradation at physiological conditions (pH = 7) but exhibits a rapid hydrolysis at mild acidic conditions (pH = 5 5.5) which are naturally present in many tumoral tissues, as a consequence of their accelerated metabolism and the hypoxic environment. 17 Thus, the enzyme will stay in an inactive stage until the pH becomes acidic, which will trigger the enzyme release with the subsequent collagen matrix degradation.
Collagenase nanocapsules (Col-nc) were synthesized forming a polymeric coating around the native collagenase (Col) by radical polymerization employing a monomer mixture of acrylamide (AA) as structural monomer, hydrochloride salt of 2-aminoethylmethacrylate (Am) in order to provide amino groups on the capsule surface and ethylene glycol dimethacrylate (EG) as pHcleavable cross-linker. Different conditions were tested until the following optimal capsule formation parameters were found: monomer/protein molar ratio of 1:2025 and AA:Am:EG ratio The presence of free amino groups on the capsule surface was confirmed by fluorescamine assay. The enzymatic activity of the capsules was determined using a commercial kit (EnzCheck Gellatinase/Collagenase, Molecular Probes®) which is based in the measurement of the fluorescein released when fluorescently labeled gelatin was exposed to enzyme degradation.
After the encapsulation process, the enzymatic activity suffers a drastic reduction of around 50% which indicates that the polymeric coating significatively hampers the collagen degradation by the encapsulated enzyme ( Figure S1a ).
This fact confirms that the enzyme should be released in order to achieve an efficient degradation of the collagen matrix, as it was mentioned above. by DLS as the native enzyme, whereas the capsule exposed to neutral pH did not suffer any size modification. Interestingly, the enzymatic activity was almost fully recovered after the acidic treatment but it was kept at 50% when the sample was maintained at pH = 7. These results are consistent with a complete release of the trapped enzyme (Figure 2) . Attachment of collagenase nanocapsules on the nanocarrier surface.
Mesoporous silica nanoparticles (MSNs) have been chosen as nanomedicine model due to the excellent properties of this material such as high loading capacity and excellent biocompatibility, among others. 18, 19 Thus, MSNs were synthesized following the modified Stöber method reported elsewhere. 20 According to DLS and TEM, the particles show a homogeneous size distribution centered around 140 nm which is convenient for their application as drug nanocarriers. 21 In order to provide anchoring points for the protein nanocapsules, the surface of the particles was decorated with carboxylic groups by condensation of 4-(trietoxisililetilene)succidimide with the silanol groups on the surface, followed by hydrolysis in acidic medium. The presence of carboxylic groups was confirmed by the apparition of the characteristic C=O band at 1710 cm -1 in the Fourier-Transform Infrared (FT-IR) spectrum and by Thermogravimetric Analysis (TGA).
According with the DLS measurements, the particle size was maintained during this functionalization process ( Figure S2 ).
Enzyme nanocapsules were covalently grafted on the MSNs surface through the well-known carbodiimide chemistry. Thus, the carboxylic groups present on the MSN were transformed into 
Stability of MSN-Col-nc
Obviously, MSN-Col initially presents higher enzymatic activity than MSN-Col-nc ( Figure   S1b ) mainly by two reasons, first the absence of a polymeric coat as it has been mentioned above and secondly, the higher steric hindrance of the capsules which causes a lower enzyme nanocapsules grafting in comparison with the native protein attachment. However, despite this initial advantage, the enzymatic activity of MSN-Col decreases in a short period of time when 11 the samples are suspended in a PBS buffer solution at pH = 7 and 37 ºC whereas the activity increases to double its initial value in the case of MSN-Col-nc. This behavior proves that the polymeric coat which wraps the enzyme suffers hydrolysis and the housed enzymes are slowly released or exposed fully recovering their capacity to digest collagen after longer periods of time (Figure 4a) . It is important to remark that a similar amount of free enzyme almost completely loses its activity after a short incubation time of two hours in these conditions. One important role which should be played by the polymeric coat consists in the protection of the encapsulated enzyme against proteolytic attack, because the lack of stability against proteases is the main limitation on the use of proteins in clinical applications. 22 In order to compare the stability against proteases, samples MSN-Col and MSN-Col-nc were suspended at 37 °C in a solution of PBS (pH = 7) which contains 1 mg·mL -1 of Protease from Streptomyces griseus. The results indicate that material with the uncoated enzyme lost more than 60% of its enzymatic activity after 3 hours while the sample with enzyme nanocapsules kept intact their activity (Figure 4b ).
All these experiments evidence the protective role of the polymeric nanocapsules. 
EMC degradation capacity of MSN-Col-nc
The capacity of the protein capsules attached on the particle surface to degrade the extracellular matrix was initially tested using a 3D collagen matrix formed by MaxGel TM ECM.
This 3D matrix is composed by several human extracellular matrix components such as collagen, laminin, fibronectin, tenascin, elastin, and a number of proteoglycans and glycosaminoglycans which mimic the matrices present in human living tissues. 11 The proteins which form the 3D matrix were previously stained with fluorescein isothiocyanate (FITC) in order to monitorize the 13 matrix degradation through the measurement of the fluorescein released after addition of the nanoparticles. Naked MSN, which shows negligible enzymatic activity ( Figure S4 ) was used as control. A suspension of 1 mg·mL -1 of MSN-Col-nc and MSN respectively, was carefully added on top of the fluorescent 3D gels and both samples were incubated at 37 °C during 24 hours.
After this time, a strong fluorescence was observed in the case of MSN-Col-nc whereas a scarce fluorescence was observed in the case of naked MSN (Figure 4c) . 
Cytotoxicity studies of MSN-Col-nc.
It has been reported that collagenase, both alone 23 or conjugated on the surface of different nanoparticles 24, 25 causes very low toxicity in human cells. Additionally, MSN is also a biocompatible material. 26 However, our system is composed by a novel type of collagenase nanocapsules grafted on the MSN surface and its cytotoxicity should be evaluated. Thus, HOS cells were incubated in the presence of a fixed concentration of naked MSN and MSN-Col-nc (25 µg·mL -1 , which is the optimal concentration for tissue penetration) during 24 hours and their cell viability was evaluated measuring the Lactate deshydrogenase (LDH) released in the media.
As shown in Figure 6a , the exposition to naked particles and particles decorated with the enzyme nanocapsules did not cause higher LDH release in comparison with the negative control which corresponds to untreated cells. In order to simulate a highly cytotoxic material, as positive control, the cells were exposed to a solution of Triton X (2%) which caused their complete destruction and a subsequent LDH increment of more than four times. The absence of cytotoxicity caused by the exposition to these materials was confirmed using the standardized cell viability test by MTS reduction that exhibit similar values in all systems (Figure 6b) . These results indicate that neither of the materials provokes a substantial cell death.
16 In order to visualize if the nanoparticles were internalized within the tumoral cells, the lysosomes were stained using Cell Navigator TM Lysosome Staining Kit showing that the nanoparticles were mainly located within these cell organelles (Figure 6c-d For penetration studies within 3D gels, fluorescent nanoparticles were synthesized following an analogous protocol described elsewhere. 27 Briefly, FITC (1mg) and APTES (2,2 µL) were dissolved in the minimum volume of EtOH and the mixture was stirred at room temperature for 2 hours under N2 atmosphere. Then, this solution was mixed with 22. 4 mmol of TEOS and the particles were synthesized following the same method mentioned above. Another batch was placed into a pur-A-lyzer (6 kDa) submerged in 200 mL of PBS Buffer pH = 5.5 at 37 °C for 3 h and 1 h more in PBS buffer 0.01 M pH = 7 at 37 ºC in order to equilibrate the pH before performing the enzymatic activity measurements. Then, both batches were diluted 1:100 in PBS and then the enzymatic activity of the capsules solution was evaluated.
Synthesis of acid-funcionalizated

Study of the Enzymatic Activity of MSN-Col and MSN-Col-nc:
Stability during the time: 2 mg of silica nanoparticles functionalized with native and encapsulated collagenase (Col and Col-nc, respectively) were suspended in PBS 0.01M at pH = 7
at 37 ºC and their enzymatic activity was studied at different times. Preparation of 3D-Human Osteaosarcoma-seeded collagen gels: 2 mL of rat tail CollagenType I and 0.6 mL of complete medium (Dulbecco's modified eagle's medium complemented with 10% of FBS) were mixed in cold and 100µL of sodium hydroxide were added to obtain a mixture of neutral pH. To this solution, 0.5 mL of FBS, 0.5mL of complete medium and 0.5 mL of a solution of cells of concentration HOS 1:10 6 cell/mL was added, keeping the temperature at 0 ºC. The mixture was pipetted into 12 well plates (0.5mL/well) and incubated at 37 °C at 5% CO2 atmospheric concentration for 1 h to promote gel formation. Then 500 µL of complete medium was added in each well and the gel was incubated at 37 °C at 5%
Study Enzymatic activity against proteases:
CO2 atmospheric concentration overnight. After this time, a needle was run around the edge of each solid gel to detach it from the plastic and 0.5 mL of complete medium was added. Gels were used in experiments four days after detachment to allow full gel contraction.
Study of penetration of MSN-Col-nc in HOS-collagen gels:
To study the penetration of nanocarriers in 3D gels with cells HOS embedded, the medium which cover the gels was removed and the corresponding amount of suspended MSN and MSN-Col-nc (1 mg ·mL -1 ) was added on top of each gel. These samples were incubated at 37 °C at 5% CO2 atmospheric concentration during 24h. Then, the supernatant was removed and the gel was fixed at 4 ºC during 1 h with 0.5 ml of a solution of glutaraldehyde at 2.5 % of concentration. Then, confocal fluorescence microscope (using 10x magnifications) was used to determine the penetration by zstack images of each gel, composed of sequential images taken 2 µm apart. Each compressed zstack was analyzed and used for statistical analysis and graphical representation.
Cell viability studies:
The cytotoxicity of nanocarriers was evaluated using the standard LDH activity test and the MTS reduction assay protocol. For this study 20000 cells HOS·cm -2 were seeded into each well of a 24 well plate, 0.5mL of complete media was added to each well and the cells were cultured at 37 °C at 5% CO2 atmospheric concentration for 24h. Then, the cells were incubated with the corresponding sample MSN and MSN-Col-nc, at 25 µg·mL -1 or without particles in the case of controls (+) and (-), during 24 h at 37 °C at 5% CO2 atmospheric concentration. In the case of control (+) a suspension of Triton X (2%) was added and the cells were incubated during 2h.
After this time, the supernatant was collected for measuring the extracellular LDH activity. The cells were washed with 0.5 mL of PBS twice and 0.3 mL of a solution of 2 mL of MTS in 10 mL of complete medium was added. The cell culture was incubated at 37 °C at 5% CO2 atmospheric concentration for 4h and then the supernatant was collected for the MTS assay.
Lactate dehydrogenase (LDH) assay: Extracellular LDH activity was measured using 33 µL of supernatant and 1000 µL of the kit for Quantitative determination of LDH (Spinreact®). The LDH activity was measured by spectrophotometer at 340 nm in the culture medium following the manufacturer protocol.
MTS assay:
The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) reduction assay was performed using a commercial assay and following the manufacturer protocol (CellTiter® Aqueous One Solution Cell Proliferation Assay). The absorption of supernatant was measured at 490 nm using a microplate reader.
Fluorescence microscopy images of HOS exposed to MSN and MSN-Col-nc.
For this study, HOS cells were exposed during 24 h to the same nanoparticle concentration (25 µg·mL -1 ) of MSN and MSN-Col-nc covalently labeled with fluorescein as in the previously mentioned assays.
In order to visualize lysosomes, a staining kit (Cell Navigator TM Lysosome Staining Kit) was employed. Briefly, 20 µl of LisoBrite TM Red, 4.98 ml of Live Cell Staining Buffer and 5 ml of complete media were mixed. 600 µl of these dilutions were added into each well of a 24 well plate which contains the cells and they were incubated for 30 min at 37 ºC. Then, the supernatant was removed and the cells were washed with 0.5 mL of PBS twice. To visualize the cells nuclei, 600 µl of 1 µg/ml DAPI in methanol was added into each well and the cells were incubated for
